Quimi Daphne Insider Trades

Insider Trading History

Track insider trading activity for Quimi Daphne. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $91.1k 44,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.4k 44,000 shares
$0.60
$2.07
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $330k 25,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 25,000 shares
$5.05
$13.20
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $10.4k 5,000 shares
Last Trade
Sep 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.65k 5,000 shares
$1.53
$2.07
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $91.1k 44,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 44,000 shares
$2.69
$2.07
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $330k 25,000 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 25,000 shares
$1.76
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $66k 5,000 shares
Last Trade
May 15, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.25k 2,250 shares
$1.89
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $36.3k 2,750 shares
Last Trade
May 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.2k 2,750 shares
$1.89
$13.20
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $91.1k 44,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 44,000 shares
$3.19
$2.07
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $224k 16,985 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 16,985 shares
$26.25
$13.20
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $5.77M 398,532 shares
Last Trade
Jan 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$90k 6,923 shares
$13.00
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $5.88M 405,455 shares
Last Trade
Jan 17, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.5k 5,000 shares
$12.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $5.95M 410,455 shares
Last Trade
Jan 11, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$355k 29,565 shares
$12.02
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $6.38M 440,020 shares
Last Trade
Jan 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$707k 58,824 shares
$12.02
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $5.52M 381,196 shares
Last Trade
Jan 04, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.7k 3,884 shares
$12.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $5.58M 385,080 shares
Last Trade
Jan 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$102k 8,575 shares
$11.93
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $4.64M 320,147 shares
Last Trade
Jan 02, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$185k 15,165 shares
$12.21
$14.49
Century Therapeutics
Century Therapeutics IPSC
Director
Holding Value $82.3k 39,744 shares
Last Trade
Oct 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$393k 39,744 shares
$9.89
$2.07
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $4.86M 335,312 shares
Last Trade
Sep 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.6k 4,397 shares
$11.29
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $4.92M 339,709 shares
Last Trade
Aug 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$69.6k 5,798 shares
$12.00
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Financial Officer
Holding Value $5.01M 345,507 shares
Last Trade
Jun 17, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.6k 4,396 shares
$9.00
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up